LA
CL icon

Lynch & Associates’s Colgate-Palmolive CL Stock Holding History

Lynch & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Sell
20,927
-352
-2% -$30.8K 0.34% 69
2026
Q1 		$1.81M Buy
21,279
+615
+3% +$54.8K 0.34% 70
2025
Q4 		$1.63M Sell
20,664
-1,815
-8% -$142K 0.31% 68
2025
Q3 		$1.8M Sell
22,479
-3,092
-12% -$264K 0.35% 64
2025
Q2 		$2.32M Sell
25,571
-35
-0.1% -$3.19K 0.47% 54
2025
Q1 		$2.4M Sell
25,606
-320
-1% -$28.7K 0.52% 50
2024
Q4 		$2.36M Sell
25,926
-781
-3% -$74.5K 0.51% 52
2024
Q3 		$2.77M Sell
26,707
-302
-1% -$30.8K 0.59% 48
2024
Q2 		$2.62M Buy
27,009
+977
+4% +$90.1K 0.59% 47
2024
Q1 		$2.34M Sell
26,032
-2,180
-8% -$185K 0.54% 51
2023
Q4 		$2.25M Sell
28,212
-534
-2% -$40.2K 0.55% 52
2023
Q3 		$2.04M Sell
28,746
-1,820
-6% -$136K 0.54% 50
2023
Q2 		$2.35M Sell
30,566
-610
-2% -$47.2K 0.6% 48
2023
Q1 		$2.34M Sell
31,176
-510
-2% -$37.9K 0.61% 48
2022
Q4 		$2.5M Buy
31,686
+91
+0.3% +$6.82K 0.65% 48
2022
Q3 		$2.22M Buy
31,595
+458
+1% +$35.9K 0.65% 48
2022
Q2 		$2.5M Sell
31,137
-36
-0.1% -$2.81K 0.68% 46
2022
Q1 		$2.36M Buy
31,173
+645
+2% +$51.1K 0.57% 47
2021
Q4 		$2.6M Buy
30,528
+75
+0.2% +$5.86K 0.62% 46
2021
Q3 		$2.3M Sell
30,453
-590
-2% -$46.8K 0.6% 47
2021
Q2 		$2.52M Buy
31,043
+630
+2% +$51.5K 0.65% 45
2021
Q1 		$2.4M Buy
30,413
+1,009
+3% +$79.1K 0.65% 46
2020
Q4 		$2.51M Sell
29,404
-500
-2% -$41.3K 0.68% 41
2020
Q3 		$2.31M Buy
29,904
+1,110
+4% +$84.6K 0.69% 43
2020
Q2 		$2.11M Sell
28,794
-435
-1% -$30.9K 0.68% 43
2020
Q1 		$1.94M Buy
29,229
+425
+1% +$30K 0.71% 45
2019
Q4 		$1.98M Sell
28,804
-51
-0.2% -$3.48K 0.57% 46
2019
Q3 		$2.12M Sell
28,855
-50
-0.2% -$3.63K 0.65% 45
2019
Q2 		$2.07M Sell
28,905
-25
-0.1% -$1.77K 0.67% 46
2019
Q1 		$1.98M Buy
28,930
+160
+0.6% +$10.3K 0.66% 46
2018
Q4 		$1.71M Sell
28,770
-2,325
-7% -$145K 0.64% 48
2018
Q3 		$2.08M Sell
31,095
-1,325
-4% -$88.3K 0.7% 44
2018
Q2 		$2.1M Sell
32,420
-75
-0.2% -$4.91K 0.76% 41
2018
Q1 		$2.33M Buy
32,495
+400
+1% +$28.8K 0.89% 39
2017
Q4 		$2.42M Buy
32,095
+781
+2% +$57K 0.91% 40
2017
Q3 		$2.28M Sell
31,314
-278
-0.9% -$20K 0.91% 40
2017
Q2 		$2.34M Buy
31,592
+2,050
+7% +$152K 0.93% 39
2017
Q1 		$2.16M Buy
29,542
+1,175
+4% +$82.2K 0.88% 41
2016
Q4 		$1.86M Sell
28,367
-24
-0.1% -$1.65K 0.78% 43
2016
Q3 		$2.1M Sell
28,391
-181
-0.6% -$13.4K 0.93% 40
2016
Q2 		$2.09M Sell
28,572
-90
-0.3% -$6.41K 0.93% 36
2016
Q1 		$2.02M Buy
28,662
+1,725
+6% +$115K 0.96% 36
2015
Q4 		$1.79M Sell
26,937
-125
-0.5% -$8.31K 0.92% 37
2015
Q3 		$1.72M Sell
27,062
-200
-0.7% -$13.1K 0.95% 38
2015
Q2 		$1.78M Buy
27,262
+425
+2% +$28.8K 0.93% 35
2015
Q1 		$1.86M Buy
26,837
+1,320
+5% +$91.2K 0.98% 35
2014
Q4 		$1.76M Buy
25,517
+290
+1% +$19.6K 0.95% 35
2014
Q3 		$1.65M Sell
25,227
-266
-1% -$17.5K 0.92% 37
2014
Q2 		$1.74M Buy
25,493
+75
+0.3% +$5.03K 0.99% 35
2014
Q1 		$1.65M Buy
25,418
+329
+1% +$20.7K 0.97% 36
2013
Q4 		$1.64M Buy
25,089
+420
+2% +$26.9K 0.98% 35
2013
Q3 		$1.46M Sell
24,669
-100
-0.4% -$5.92K 0.98% 35
2013
Q2 		$1.42M Buy
+24,769
New +$1.47M 0.98% 32

Other funds holding CL

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.57B AUM 35.56% 1-Year Est. Return

Lynch & Associates's CL Position: Q2 2026 in Review

Lynch & Associates reduced its Colgate-Palmolive (CL) stake by 1.7% in Q2 2026, selling an estimated $30.8K and leaving 20,927 shares worth $1.92M. The position accounts for 0.34% of the portfolio, ranked #69.

Lynch & Associates first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.77M in Q3 2024. 333 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Lynch & Associates held 20,927 shares of Colgate-Palmolive worth $1.92M as of Q2 2026.
  • Lynch & Associates sold 352 Colgate-Palmolive shares in Q2 2026, an estimated $30.8K.
  • Colgate-Palmolive made up 0.34% of Lynch & Associates's portfolio in Q2 2026, its #69 holding.
  • Lynch & Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Lynch & Associates's Colgate-Palmolive position peaked at $2.77M in Q3 2024.
  • 333 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Lynch & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.